drugset / Trial / NCT05611749

Duloxetine Impact on Postoperative Pain Control and Outcomes

NCT05611749

Phase 2 Terminated 17 enrolled Scripps Health
RandomizedParallel-groupQuadruple-blindPrevention

Summary

1. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative narcotic consumption. 2. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative pain, function, and quality of life. 3. Evaluate the correlation between preoperative screening tests (measuring pain centralization, anxiety, depression, and overall function) and patients' response to treatment (reduction in pain, anxiety, or depression and improvement in function).

Timeline

Start
2023-05-30
Primary completion
2024-03-25
Completion
2024-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg